Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Sabine Fenner
Director Oligo R&D at Bachem
Speaker

Profile

Sabine completed a PhD in organic chemistry at the University of Göttingen Germany in 2012, followed by a postdoctoral stay at the University of Cambridge UK focusing on the total synthesis of a peptide-derived antibiotic. From 2014-2025 she worked as a Process Chemist and Scientific leader at GSK UK, developing small molecule and oligonucleotide drug candidates. In July 2025 Sabine joined Bachem as a director Oligo R&D where she is now concentrating on the process development of therapeutic oligonucleotides throughout clinical phases as well as the adoption of innovative technologies for a streamlined commercial API supply.

Agenda Sessions

  • From Process Development to GMP Scale: Advancing Enzymatic Ligation for Oligonucleotide Therapeutics

    , 2:00pm
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Sabine at TIDES USA: Oligonucleotide & Peptide Therapeutics